Tag: iShares NASDAQ Biotechnology ETF

Trading Strategy – iShares Nasdaq Biotechnology ETF

  One of the more noteworthy developments in recent days has been the move in biotech stocks.  The group attracted strong buying support in recent day that saw the iShares Nasdaq Biotechnology ETF (IBB) surged more than 4 percent last week, bringing its YTD gains up to 14.4 percent while the S&P gained 8.5 percent […]

Trading Strategy – iShares Nasdaq Biotechnology ETF

  Biotech caught a bid Friday after Biogen announced positive results from a study on a drug aimed at treating early Alzheimer’s disease, its shares rose nearly 20 percent.  The iShares Nasdaq Biotechnology ETF (IBB) surged 3.8 percent, bringing its YTD gains up to nearly 9 percent, outperformed the S&P by a wide margin.  Now […]

Trading Strategy – iShares Nasdaq Biotechnology ETF

  One of the more noteworthy developments in recent days has been the move in biotech.  The iShares Nasdaq Biotechnology ETF (IBB) now up about 12% from its November lows to trade at 112, near two-year nigh.  Not only is that IBB overbought following recent advance, the ETF also drawing the attention of bears.  Now […]

Trading Strategy – iShares Nasdaq Biotechnology ETF

  Healthcare stocks come back into the spotlight following report that Senate Majority Leader Mitch McConnell plans to bring a last-ditch bill to repeal and replace big parts of Obamacare to a vote in the Senate next week. The iShares Nasdaq Biotechnology ETF (IBB) rose 0.85 percent to 332.75. The ETF has risen more than […]

Next Page »